A Study of Regorafenib Combined With Envafolimab for Metastatic Gastrointestinal Stromal Tumors With Kit Gene Exon 17 Mutation That Failed Standard Treatment
Clinical trial NCT06772233 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06772233
- Sponsor
- Peking University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-30
- Primary completion
- 2027-07-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.